SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-07-195636
Filing Date
2007-09-05
Accepted
2007-09-05 15:52:57
Documents
6
Period of Report
2007-08-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 18900
2 PLACEMENT AGENT AGREEMENT dex11.htm EX-1.1 28950
3 CERTIFICATE OF DESIGNATIONS, PREFERENCES AND RIGHTS dex31.htm EX-3.1 101451
4 OPINION OF ROPES & GRAY LLP dex51.htm EX-5.1 8370
5 PURCHASE AGREEMENT dex991.htm EX-99.1 145584
6 PRESS RELEASE dex992.htm EX-99.2 8567
  Complete submission text file 0001193125-07-195636.txt   313321
Mailing Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111 212-994-8200
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 071099951
SIC: 2836 Biological Products, (No Diagnostic Substances)